Literature DB >> 1699223

Energetics of RNA cleavage: implications for the mechanism of action of ribozymes.

K Taira1, M Uebayasi, H Maeda, K Furukawa.   

Abstract

A new class of ribozymes produce 2',3'-cyclic phosphate upon self-catalyzed cleavage of RNA molecules, similar to those observed during enzymatic (RNase-catalyzed) as well as non-enzymatic hydrolyses of RNAs. This product suggests that the reaction intermediate/transition state is a pentacoordinated oxyphosphorane. In order to elucidate the energetics of these RNA cleaving reactions, the reaction coordinate has been simulated and a pentacoordinated intermediate has been characterized via ab initio molecular orbital calculations utilizing the dianionic hydrolysis-intermediate of methyl ethylene phosphate as a model compound. The calculated reaction coordinate indicates that the transition state for the P-O(2') bond cleavage is lower in energy than that for the P-O(5') bond cleavage under uncatalyzed conditions. Thus, the dianionic pentacoordinated phosphorus intermediate tends to revert back to the starting RNA by cleaving the P-O(2') bond rather than productively cleaving the P-O(5') bond. In order for ribozymes to effectively cleave RNA molecules, it is therefore mandatory to stabilize the leaving 5'-oxygen, e.g. by means of a divalent magnesium ion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699223     DOI: 10.1093/protein/3.8.691

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  13 in total

Review 1.  Recent advances in the elucidation of the mechanisms of action of ribozymes.

Authors:  Y Takagi; M Warashina; W J Stec; K Yoshinari; K Taira
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Comparison of the hammerhead cleavage reactions stimulated by monovalent and divalent cations.

Authors:  J L O'Rear; S Wang; A L Feig; L Beigelman; O C Uhlenbeck; D Herschlag
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

3.  Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.

Authors:  T Kuwabara; M Warashina; T Tanabe; K Tani; S Asano; K Taira
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  Random mutations to evaluate the role of bases at two important single-stranded regions of genomic HDV ribozyme.

Authors:  P K Kumar; Y A Suh; H Miyashiro; F Nishikawa; J Kawakami; K Taira; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

5.  Deletion of internal sequence on the HDV-ribozyme: elucidation of functionally important single-stranded loop regions.

Authors:  Y A Suh; P K Kumar; F Nishikawa; E Kayano; S Nakai; O Odai; S Uesugi; K Taira; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

6.  Configurationally defined phosphorothioate-containing oligoribonucleotides in the study of the mechanism of cleavage of hammerhead ribozymes.

Authors:  G Slim; M J Gait
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

7.  Rate limiting P-O(5') bond cleavage of RNA fragment: ab initio molecular orbital calculations on the base-catalyzed hydrolysis of phosphate.

Authors:  K Taira; T Uchimaru; K Tanabe; M Uebayasi; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

8.  Structural and Biochemical Studies on the Reaction Mechanism of Uridine-Cytidine Kinase.

Authors:  Fumiaki Tomoike; Noriko Nakagawa; Seiki Kuramitsu; Ryoji Masui
Journal:  Protein J       Date:  2015-12       Impact factor: 2.371

9.  Probing the hammerhead ribozyme structure with ribonucleases.

Authors:  R A Hodgson; N J Shirley; R H Symons
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

10.  Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.

Authors:  T Shimayama; F Nishikawa; S Nishikawa; K Taira
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.